Literature DB >> 9657094

Increased cerebrovascular resistance in cirrhotic patients with ascites.

M Guevara1, C Bru, P Ginès, G Fernández-Esparrach, P Sort, R Bataller, W Jiménez, V Arroyo.   

Abstract

Studies assessing regional hemodynamics in patients with cirrhosis and ascites have shown vasodilation in the splanchnic circulation and vasoconstriction in the renal circulation and in the brachial and femoral artery vascular territories. The aim of this study was to assess the cerebral vascular resistance in cirrhotic patients with ascites. The resistive index in the middle cerebral artery (an index of the cerebral vascular resistance) and in a renal interlobar artery were measured by Doppler ultrasonography in 7 healthy subjects: 13 patients with compensated cirrhosis and 24 patients with ascites (13 with renal failure). The arterial blood pressure and the activity of the renin-angiotensin and sympathetic nervous systems, as estimated by plasma renin activity and plasma norepinephrine concentration, respectively, were also measured. The resistive index in the middle cerebral artery was significantly increased in patients with ascites (0.68 +/- 0.05, mean +/- SD) as compared with patients without ascites (0.60 +/- 0.01, P < .05) and with healthy patients (0.52 +/- 0.01, P < .01). Renal resistive index was also increased in patients with ascites (0.77 +/- 0.01) compared with the other two groups (0.68 +/- 0.02 and 0.62 +/- 0.00, respectively; P < .001). The resistive index in the middle cerebral artery showed a direct correlation with renal resistive index (r = .73, P < .01), plasma renin activity (r = .61, P < .01), and norepinephrine (r = .53, P < .01). The resistive index in the middle cerebral artery showed an inverse correlation with mean arterial pressure (r = -.45, P < .01). These results indicate that in patients with cirrhosis and ascites there is a cerebral vasoconstriction which is probably related with the arterial hypotension and the overactivity of vasoconstrictor systems.

Entities:  

Mesh:

Year:  1998        PMID: 9657094     DOI: 10.1002/hep.510280107

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

Review 1.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 2.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Authors:  Francesco Salerno; Alexander Gerbes; Pere Ginès; Florence Wong; Vicente Arroyo
Journal:  Gut       Date:  2007-03-27       Impact factor: 23.059

Review 3.  Clinical use of albumin in hepatology.

Authors:  Matteo Garcovich; Maria Assunta Zocco; Antonio Gasbarrini
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

4.  Vascular Doppler ultrasonographic indices in cirrhosis: a case-control study with emphasis on the common carotid arteries.

Authors:  Abolhassan Shakeri; Mojtaba Varshochi; Naser Atapour; Masoud Nemati; Manoochehr Khoshbaten; Daniel Fadaei Fouladi
Journal:  Radiol Med       Date:  2015-03-01       Impact factor: 3.469

Review 5.  Acute kidney injury in patients with cirrhosis: perils and promise.

Authors:  Justin M Belcher; Chirag R Parikh; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-10       Impact factor: 11.382

Review 6.  Pathophysiology of brain edema in fulminant hepatic failure, revisited.

Authors:  A T Blei
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

7.  Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.

Authors:  Gang Zheng; Hanzhang Lu; Wenkui Yu; Song Luo; Ya Liu; Wei Liu; Hui Liu; Long Wu; Lijuan Zheng; Xiang Kong; Long Jiang Zhang; Guang Ming Lu
Journal:  Eur Radiol       Date:  2017-05-18       Impact factor: 5.315

8.  Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis.

Authors:  Jasmohan S Bajaj; Vishwadeep Ahluwalia; James B Wade; Arun J Sanyal; Melanie B White; Nicole A Noble; Pamela Monteith; Michael Fuchs; Richard K Sterling; Velimir Luketic; Iliana Bouneva; Richard T Stravitz; Puneet Puri; Kenneth A Kraft; Hochong Gilles; Douglas M Heuman
Journal:  J Hepatol       Date:  2012-08-11       Impact factor: 25.083

Review 9.  Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Authors:  Massimo Bolognesi; Marco Di Pascoli; Alberto Verardo; Angelo Gatta
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 10.  Ammonia toxicity: from head to toe?

Authors:  Srinivasan Dasarathy; Rajeshwar P Mookerjee; Veronika Rackayova; Vinita Rangroo Thrane; Balasubramaniyan Vairappan; Peter Ott; Christopher F Rose
Journal:  Metab Brain Dis       Date:  2016-12-24       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.